Skip to main content
. Author manuscript; available in PMC: 2014 Jul 9.
Published in final edited form as: Ann Surg. 2012 Sep;256(3):487–493. doi: 10.1097/SLA.0b013e318265819c

Table 1. Demographic and Preoperative Baseline Characteristics of Patients Undergoing Pulmonary Resection.

Characteristic Open n = 8439 n (%) VATS n = 4531 n (%) Total n = 12970 n (%) P
Age at time of surgery n = 8436 n = 4525 n = 12961 0.001
 Mean ± SD 66.9 ± 10.4 67.5 ± 10.3 67.1 ± 10.4
Sex n = 8432 n = 4530 n = 12962 <0.001
 Female 4193 (49.7) 2529 (55.8) 6722 (51.9)
 Male 4239 (50.3) 2001 (44.2) 6240 (48.1)
Diabetes n = 8333 n = 4483 n = 12816 0.014
1384 (16.6) 670 (14.9) 2054 (16.0)
Creatinine ≥ 2.0 195 (2.3) 93 (2.1) 288 (2.2) 0.34
Coronary artery disease n = 7497 n = 4108 n = 11605 <0.001
1924 (25.7) 887 (21.6) 2811 (24.2)
Congestive heart failure n = 7465 n = 4095 n = 11560 0.003
302 (4.0) 121 (3.0) 423 (3.7)
Current smoker 0.002
 Never or past smoker 6118 (72.5) 3399 (75.0) 9517 (73.4)
 Current smoker 2321 (27.5) 1132 (25.0) 3453 (26.6)
COPD n = 2937 n = 2258 n = 5195 <0.001
1083 (36.9) 730 (32.3) 1813 (34.9)
FEV predicted <0.001
 Mean ± SD 79.3 ± 20.4 83.7 ± 20.9 80.8 ± 20.7
DLCO predicted <0.001
 Mean ± SD 72.4 ± 21.4 74.9 ± 21.8 73.2 ± 21.6
Pathologic stage n = 8097 n = 4425 n = 12522 <0.001
 I 5482 (67.7) 3472 (78.5) 8954 (71.5)
 II 1337 (16.5) 474 (10.7) 1811 (14.5)
 III 1080 (13.3) 414 (9.4) 1494 (11.9)
 IV 198 (2.4) 65 (1.5) 263 (2.1)
Preoperative chemotherapy n = 7470 n = 4082 n = 11552 <0.001
1155 (15.5) 327 (8.0) 1482 (12.8)
Preoperative X-ray therapy n = 7475 n = 4103 n = 11578 <0.001
890 (11.9) 253 (6.2) 1143 (9.9)